Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Go ahead my friend, but my feelings is this is very much done.
Eddy lets use the officers and directors can only be paid in equity for there services to get this moving.
Who do you have working for you.
http://pavilionservices.com/business-valuations/business-valuation-methods/
Wow! nothing today. I never can sense how the market will react in times of need.
Sperm are the male sex cells. They take 74 days to form, another 26 days to mature and pass through the epididymis and vas deferens and they can survive in the female for up to five days.
Is that a true statement? If so then where would be the world population be today. Do you know what your buying?
http://yourselfseries.com/teens/topic/reproduction/the-male-reproductive-system/
LOOK OUT BELOW !!!!!!!!!!!!
That is a though question to say for sure what will happen there is so many outcomes that could take place.
So are these shares gonna be disolved worthless or swapped over to new company ?
Investors are looking for hope and that is what we are doing is giving hope at a minimal charge if they understand how fractional shares work in a stock reversal as well as capital input when investing.
Time comes around for those who understand how it works in there favor.
from $.01 to $.025 maybe
This stock must drop considerably before there is another rally. The margins on the risk is not there right now maybe at $.01 Sly we will see it happen.
lets get thru 0.045 and off the races we go!
ARE YOU BEING HEARD?
http://ih.advfn.com/p.php?pid=nmona&article=65990464
Not all shareholders are created equal. At the darkest hour, when most common shareholders of EXM are about to get wiped out, company insider & majority shareholder Gabriel Panayotides lives to see another day. He gets to apply $20 million of funds already committed to the company, plus an additional $10 million, to acquire 60% of the new equity. He gets an option, should things go well over the next two years, to raise its equity stake to 75% for an additional $20 million. During this initial two-year period, he will also keep control of the company by having the right to appoint a majority of board members. Now here is a fine example of value creation that unfortunately is unavailable to the rest of us.It can be a dog it dog world we live in.
We have given some thought to double entries when it comes to debt but we haven't talked about inventory.
We knows treasury stocks is part of inventory as well capital surplus stocks repurchased for sale is also part of that inventory where one has a fixed price and the other does not.
What we haven't talked about is where the company can combine the two to make a whole so as to sell the other but we will leave that for the moment do to it,s complex nature of the subject.
The thing is to be able to figure out what is producing revenue, the buying and selling of equity the selling of assets or goods and services.
Goods and services has been talked about in reference to the income statement, where retained earnings is the other broken down into its parts stated in the equity section on the balance sheet that by the way is not a different company as many think it is.
There is also depreciation noted in the assets that has to add up too services as well as inventory purchased to keep the equipment running.
So as much as we don't like to put that into the mix it is important how the inventory number can reflect assets.
example if you where to have a part on the shelf for a metal break as example used in the shop chances are it will sit in inventory for some time and when used after depreciation due to lost interest and granted it still being new will add little value to the fixed metal break should it be fixed in the same accounting period and it due to its depreciation eve as a new component but because of its shelf depreciation adds really zero value to the bottom line but over time it does due to lost earnings on capital and capital depreciation lost interest earned that reflects inflation.
The up side is we have had very low depreciation due to low interest rates so little lost in on the shelf long term inventory so little lost in tax recovery over the time period as long as the initial price of the part has not dropped to over supply of the part due to demand caused by cheap interest rates.
yes for that application it is true and does change the picture some. It is the importance of understanding your rules that truly puts perspective on your understanding of what is happening and not just speculation.
http://finra.complinet.com/en/search/search.html?allbox=1&and_words=subsections&rbid=2403&sortorder=0&start=0&submitted=1
is that not true by the stated rules Sly?
Yes your right Tim, the SEC rules at the library says what is on line as long as you know who the rules are referenced too and this is where it is not all together clear on the internet as to who it is referenced too.
Tim think about it you can't sell nothing but you can sell something for far more then it was initially worth. The equity holders hold the T bills or what is left of them as new assets are purchased and depreciated as material is altered to create something else, a bathroom as example for employees or education, increase promotion add costs ect. on declining sales.
It is there my friend in the articles of corporation.
So Sly you should of told us that treasury stock was nothing more then T Bills that is held for collateral for debt held. The assets then are nothing more then a building sold from borrowed equity from insiders and there is and never besides the revenue from the T bills that go's too the creditors who underwrote the T bills.
Just how do you think volume will be pumped up here unless you can change the old T bills for new ones should interest go up keeping the old agreement with the underwriters on interest to be paid.
We need that agreement between the underwriters and the company on the money borrowed.
Why has the contract on the T bills changed. One has to first look at the 65 and over investor as well of the chance interest rates will go up on T bills. This has caused many pros to wait on the side line due too the chance the bond could drop in value with a rise in T bills interest rates.
There is also the dim outlook at this time for the drug from many third party users and there views.
Stay tuned this will have another day on auction at a much higher price then seen today.
http://www.investopedia.com/terms/t/treasurybond.asp
A company goes out and buys treasury bonds through a underwriter and sells those bonds, The bonds face value is the par value as noted they are held as collateral for the borrowed money and once sold becomes share holders debt.
So they are revered to as convertible T bonds or Tim bonds due to there huge initial asking price based on the business outcome.
The debt still has to be paid to the underwriters on the bond that is done by selling the bond. This still leaves a gap between the assets and liabilities that is covered by the capital surplus or you hope it to be covered.
Eddy you can still have a 100% capital invested if you invest less then 10% in many multiple sub entities to the parent company that has to be filed but with that the parent company could be 10% of a 100% and hold all the debt while the others holds the assets that is used for collateral.
So this leaves you short 10% on collateral of the reported company leaving the liability being higher then the stated asset value held as collateral or leased if not for a better term to account for assets held under a debt agreement.
I think as you noted the other day you can't sell nothing and that takes us back too the par value and how that number is used in with stock splits on the float along with the outstanding shares that is revenue owed that has been reinvested plus the all numbers in thousand thing.
Example: you have a par value of $.0001 times a thousand = a dollar at the time of distribution of public equity.
The shares have forward split 4 times that gives a value of $4.00. Now that value includes outstanding shares owed in interest as well as assets that back the debt but remember there is nothing backing the interest owed " the out standing shares "
So the par value is the value of a share today taking into account interest owed but only the principal of the loan holds collateral.
This gives a risk associated to the interest owed form the capital invested by the company.
How much credibility should an investor give to the interest being paid and why does a company take such risk in reinvesting capital with no collateral attached.
The answer to this is they have taken collateral in the way of equity " retained earnings" that because it is associated on the balance sheet not the income and cash flow statements it is noted that when a number appears in a bracket on a balance sheet the number is not in thousand as stated that all numbers are in thousands.
The reason that is is that revenue is a number that is changing by the moment the second or nano second if you like and in that nano second it can be a negative or positive and there is no way communication can be that fast so in fact the number is not important as what is owed in interest as well as what is held in collateral for the principal loaned but yet it is the very reason that capital was loaned without the required collateral.
Yo Eddy here What we are going to do is go and explain what most of you should of gotten from the library to again increase the understanding as to o how this all works.
First thing to understand is a public company is no more then a lending institution a bank if you like not for a better term.
How this works is if a public company lends more then 10% of its capital to a corporation it must file this. If less then 10% of its capital it does not have to file.
Now this means you can have 11% loaned too company A and the rest of the capital split between maybe a hundred other companies at all different interest rates agreements.
The outstanding shares represents what is owing to shareholders that has been reinvested. A public company cannot buy another's equity but for most loans holds convertible shares as collateral that can also be part of the outstanding shares but is differentiated by the capital surplus from what is owed too shareholders in outstanding shares.
Now lets say a company that was loaned money did go into BK, what happens? Well if there was collateral the company would get first dips on the spoils and again this is were the capital surplus is important to understand how it plays a roll in the outstanding shares.
So the company ends up with the assets in payment of the loan what the company would do and required to do is spin off those assets into its own stand alone entity and again taking on the debt for its shareholders.
Or it can sell of the assets and take a loss including a right down on the outstanding shares owed including capital surplus.
This may help a lot of you to make sense of the numbers in the financials.
So why are the financials not reported. There is no revenue from the 10% major debt holder and so no change in the financials until the matter is dealt with this does not mean other interests are not making money but there is a huge uncertainty of the outcome of the greater then 10% capital debt holder of the companies capital.
That is under writing debt for the most part for public companies that smaller companies are often made deals through banks larger ones like GM capital, Kodak capital due deals on there own.
So liability how does that work well that is shareholders input or capital into the public company that the company owes. Assets is collateral for money lent too private companies that has collateral.
I hope this helps many to understand how public companies work but do get to your local library and dig up the truth for your self, do your own DD don't just except the words of some guy on the net that has spouted endless BS from the first day he has arrived on the scene.
Hey Eddy " Mr. Canada " are you around can you give PL a call.
So we have reestablished the terms intrinsic value as something that doesn't belong and as many of you have picked up on the fact that it is nothing more then another term for shares held by the company for sale.
Now we have also stated that you can't sell nothing for something in the public market place hence we have a given term for this.
This value is established by buying material a 2X4 as an example and cutting it up and nailing it into a preformed shape to be later assembled into a building. This can be done with through many objects as well services through the training of personal ect.
So as this future value increases so does the opportunity too reinvest the extended wealth created by this activity.
Now how is it that additional shares are sold throughout this process. This is done by depreciation as well as appreciation of equity offered as well as the 2x4 being cut and built into a finished product.
This allows a company to short a stock or go long on a stock but at no time can they deviate from the 3% value figure without triggering a failed to deliver that they have to cover in three days or be fined for every day they miss.
Do your own DD and visit your local library to find the answers for your self how it really works.
Day trading is your friend and market makers are forced by law to buy and trade as well as add additional shares into the mix of things.
We have spent some time talking about piggy backed shares but if one was to follow the sec rules of fair play we can conclude that this can't be true.
So lets examine how this could be done. We know that through the SEC rules that there must be equal value " equality " to sell the shares and that even if he shares are picked up by the company they must pay fair value a well sell the shares for the same value with in 3% of that value be it below or above the fair value.
So how is this done? You would want to want to think of leasing of assets as well what the terms intrinsic value and good will truly stand for and not the internet's terminology of what good will and intrinsic value is.
A new page will be turned here and this will rise out of the dust maybe again for us too reap the rewards.
http://www.dummies.com/how-to/content/how-to-trade-in-penny-stocks.html
A very good book you can pick up at any Library.
hey bud thanks for the kind words
thanks EDDY gl to you.....I understand if you want to
make some other plays...You will do fine~
take care
tommer
No it is a meeting time that is all at the moment to put it to vote.
Ed if your on the winning side your ahead of the game if the american dollar does not fall to the Canadian dollar and yes your loss's do go up in Canadian terms should you loose but gain should you have winning trades if you bring the dollars home.
It doses raise the stake for sure on American dollar investments but does give a great hedge when investing in Canada and the United states when it comes too derivative investing that we have talked about.
with the Canadian dollar to the American dollar difference has forced the risk of investing south of the boarder too risky.
Good luck guys who are staying it is to risky for a group of us and where pulling back.
This should bust out soon!
hold onto those shares...we saw the bottom short term
http://www.investopedia.com/terms/e/eso.asp
This is what we have been talking about here for sometime. let me step back again into the past and answer that for you.
We have all taken notice of the stock options that has taken place on the income statement as a expense or it may look that way for the untrained eye .
The thing is when one looks at a asset for example the board that was cut into you purchased for $8 once cut is worth zip until it can be applied to something that restores the value of the cut board.
We also have the labor of cutting the board, the transporting the board and maybe the storing of the board until ready to use the board then more labor e required to assemble the board into its position as well as maybe paint the board along with other boards required to complete the project to where now it adds value not take away value from a business assets land ect.
There are two things that states the value once a project is completed the value that can be obtained after completion also what revenue and profits may be achieved after completion.
So the company issues first options paying the staff less for future goals of the company. This is backed up by the issuing of shares that are can't be traded " outstanding shares "
Now there is an argument that this undermines the value of the common shareholder but in fact it is a gain due to there is no capital cost to options as what there is to adding more debt.
But there is a way around that as well and that is to sell, buy and trade derivatives to off set capital costs with money borrowed. This is Known as piggy backing, leveraging on another companies stock without purchasing the stock.
The derivative holds a debt, a cost of entry ect. but what happens when the company falls out of money and now owes on the derivative the debt goes off the board as we have seen as well options are renegotiated to hold on to the all important employees issuing even more debt in the way of outstanding shares.
Now should the derivatives turn positive the opposite happens options are repurchased, dividends paid and every one is happy everyone is making money regardless of product success granted there is always risk associated with derivatives and this is were your trading skills com into effect. Buy on lowering outstanding shares and sell on any increasing of the outstanding shares " common stock value " when market cap is falling.
Don't buy into the BS. of two financials are happening cause that is not happening it is one financial with lots of leverage through the purchase of derivatives as well as the selling of derivatives.
I don't think it would be the company...it would be the company with a big shot lawyer on their butts....
who knows but a lot of trading to do in the next 2 weeks
As I mentioned March 16 is the bar date and if there was some sort of fraud or rush to judgement / sale....it is between now and then that we will hear about it. I do think management colluded in some shape or form but to be honest it is going to be hard to prove. On the other hand that is why we have overpriced ivy league lawyers.....
The whole thing reaks in my mind. That being said the easiest path to follow is follow the BK and court
Did you know that common shareholders only recd a letter allowing them to complain about the goings on last week?
COMPLETE BS
lets see what happens
tommer
Sorry. I didn't mean to tread on any sacred ground.
GLTA DNDNQ shareholders. I hope the company finds a mechanism to recover and preserve some value for commons.
JMHO.
To raise money they need to sell more shares to venture forward into a new future and that is where the word of mouth comes into play. Think $20 dollars goes a long way to getting others to buy in.
They raise more capital buy Apple stock then go public and know ones the wiser as they sell off Apple stock and invest the capital in some new kind of drug having given one share to old share holders to spread the news.
Now don't forget it is now restructured with lots of treasury stock and little outstanding shares available to purchase pushing up the price of the piggy backed shares.
The debt on the apple shares were taken away for the new shares as long as you can find someone willing too lend the Apple or who ever the shares they may borrow using a convertible note.
This is not rocket science how this works as long as someone is willing to except equity then it is not a debt for those piggy backed shares. The receiver of the equity sells it into the market much above par that was agreed apon for the equity in question what ever that piggy backed shares were Apple, general foods what ever the case may be.
Followers
|
223
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
12660
|
Created
|
07/17/05
|
Type
|
Free
|
Moderators |
Dendreon Corporation (NASDAQ: DNDN) is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development, commercialization, and manufacturing of novel therapeutics. The Company applies its expertise in antigen identification, engineering, and cell processing to produce active cellular immunotherapy (ACI) product candidates designed to stimulate an immune response in a variety of tumor types. Dendreon’s first product, PROVENGE® (sipuleucel-T), was approved by the U.S. Food and Drug Administration (FDA) in April 2010 and by the European Medicines Agency in 2013. Dendreon is exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. The Company is headquartered in Seattle, Washington and has manufacturing facilities in Georgia and California.
PROVENGE® (sipuleucel-T) is the first autologous cellular immunotherapy to receive FDA approval for the treatment of asymptomatic or minimally symptomatic metastatic castrate resistant prostate cancer. PROVENGE is designed to take the body’s own immune cells and reprogram them to attack advanced prostate cancer.
PROVENGE full Prescribing Information
For more information about PROVENGE, please visit www.PROVENGE.com.
US Health Care Professionals can visit the Medical Affairs Web site to submit a request online.
http://www.dendreon.com/products/provenge/manufacturing/
http://www.dendreon.com/products/provenge/scientific_publications/
The Patient Resources section includes information about patient access, clinical trials and patient information.
For Questions about PROVENGE® (sipuleucel-T), contact Dendreon ON Call:
Phone: 877-336-3736
Fax: 877-556-3737
http://www.dendreon.com/patient_resources/patient_access/
Dendreon has several ongoing clinical trials, including:
Sipuleucel-T Clinical Trials
P10-1
P10-2
P10-3 (called PROCEED)
P11-1
P11-3
P11-4 (PRIME)
P12-1
P12-2
Additional ACI Product Candidate Clinical Trials
N10-1 (called Neu-ACT)
To find out more about cancer and specifically prostate cancer, we have provided a list of patient-focused cancer organizations.
PipelineInvestigational product candidates in the Dendreon pipeline include:
Stock Quote (NASDAQ: DNDN) Price: 2.04 Change: + 0.03 Volume: 1,783,600 4:00 PM ET on Jun 13, 2014 Delayed at least 20 minutes. Provided by eSignal. |
Dendreon Corporation is a biotechnology company focused on targeting cancer and transforming lives through the discovery, development and commercialization of novel therapeutics that may significantly improve cancer treatment options for patients.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |